Optimization of cyclosporine monotherapy--long-term graft function
Birkeland, S.A.; Elbirk, A.; Rohr, N.; Jørgensen, K.A.
Transplantation Proceedings 26(5): 2501-2506
1994
ISSN/ISBN: 0041-1345 PMID: 7940767 Document Number: 437080
Document emailed within 1 workday
Related Documents
Hourmant, M.; Buzelin, F.; Dubigeon, P.; Soulillou, J.P. 1987: High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy Transplantation Proceedings 19(1 Pt 3): 2113-2114Miwa, H.; Van Loenen, M.; Vanderwerf, B.A. 1989: The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine Clinical Transplants 1989: 275-280
Lehtonen, S.R.; Isoniemi, H.M.; Salmela, K.T.; Taskinen, E.I.; von Willebrand, E.O.; Ahonen, J.P.; vWillebrand, E.O. 1997: Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection Transplantation 64(1): 103-107
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Laudi, S.; Weimann, J.; Haschke, M.; Trump, S.; Schmitz, V.; Christians, U.; Kaisers, U.; Steudel, W. 2007: Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 58(1): 19-32
Hoshino, Y.; Suzuki, C.; Ohtsuki, M.; Masubuchi, Y.; Amano, Y.; Chiba, K. 1996: FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine a Transplantation Proceedings 28(2): 1060-1061
Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019
Lund, F.; Thaysen, J.H.; Ladefoged, J.; Nerstrom, B. 1976: Long term survival and graft function after cadaver kidney transplantation Acta Chirurgica Scandinavica. Supplementum 472: 9-12
Braun-Dullaeus, R.C.; Feussner, M.; Walker, G.; Tillmanns, H.; Haberbosch, W. 1998: Comparison of in vitro cardiovascular function with in vivo echocardiographic assessment after long-term administration of cyclosporine to rats Journal of Cardiovascular Pharmacology 31(6): 828-832
Goulet, O.J.; Revillon, Y.; Gubler, M.C.; Kassis, B.; Jan, D.; Colomb, V.; De Potter, S.; Francois, B.; Sarnacki, S.; Ricour, C. 1994: Renal function and histomorphology after long-term intravenous administration of cyclosporine for small bowel transplantation in pediatric patients Transplantation Proceedings 26(3): 1428
Persson, H.; Frisk, B.; Smith, L.; Brynger, H. 1984: A positive prognostic factor in renal transplantation: long-term function of previous graft Transplantation Proceedings 16(5): 1174
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Sandrini, S.; Maiorca, R.; Scolari, F.; Cancarini, G.; Setti, G.; Gaggia, P.; Cristinelli, L.; Zubani, R.; Bonardelli, S.; Maffeis, R.; Portolani, N.; Nodari, F.; Giulini, S.M. 2000: A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation Transplantation 69(9): 1861-1867
Hossack, K.F.; Pool, P.E.; Seagren, S.C.; Day, B.; Bruce, R.A. 1985: Long-term monotherapy of angina pectoris with diltiazem Australian and New Zealand Journal of Medicine 15(2): 221-225
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Troppmann, C.; Gruessner, A.C.; Papalois, B.E.; Sutherland, D.E.; Matas, A.J.; Benedetti, E.; Gruessner, R.W. 1996: Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome Transplantation 61(9): 1323-1330
Wen, L.; Jiang, X.; An, P.; He, J.; Zheng, L.; Liu, Q.; Peng, F.; Xu, X.; Jing, Z. 2014: Long-term effects with ambrisentan monotherapy in patients with pulmonary arterial hypertension Zhonghua Xin Xue Guan Bing Za Zhi 42(6): 469-473
Alsamarai, S.; Zergebel, C.; Zhang, J.; Furuie, T.; Urrea, P.D.; Saif, M.W. 2008: Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer Jop: Journal of the Pancreas 9(2): 185-191
Holguín, A.; Dietrich, U.; Immelmann, A.; Soriano, V. 1998: Genotypic and phenotypic resistance to stavudine after long-term monotherapy. BMS-020 Spanish Study Group Antiviral Therapy 3(3): 183-186